MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.8000
0.00 (0.00%)
At close: May 21, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 5.83 million as of May 21, 2026. Its market cap has increased by 63.03% in one year.
Market Cap
5.83M
Enterprise Value
7.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.80
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 5.83M, a decrease of -92.70%. That is a compound annual growth rate of -57.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 5.83M | -2.78% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemostemix | 11.87M |
| Glow Lifetech | 10.58M |
| Marvel Biosciences | 10.08M |
| COSCIENS Biopharma | 7.90M |
| Innovotech | 7.35M |
| Quest PharmaTech | 6.77M |
| Kane Biotech | 6.36M |
| Aptose Biosciences | 5.95M |